/Companies

Notable Labs

YC W15YC Top Company

San Francisco, US · Founded 2014 · Delaware corporation · 40 employees · Public · Hiring · 37 known investors

Find your way into Notable Labs

Sign up to see every warm intro you have to Notable Labs

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Notable Labs team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Notable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.

Also known as Stemcycle Inc.

BiotechHealthtechMedical DevicesDrug discoveryOncologyUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W15)

Notable Labs was founded in 2014 by Matthew De Silva and Pete Quinzio.

MDMatthew De Silva
Matthew De SilvaFounder & Executive Chairman2020–2023Venture Partner, Health at Builders VC30 Under 30 2017
PQPete Quinzio
Pete QuinzioFounder, Chief Operating Officer / Chief Financial Officer, Board Member2014–2020
CW
Connor WarnockSenior Engineer
SP
Scott PattersonVice President of Engineering
JS
Jenny SpeerDirector of People
VD
Van DuesterbergScience Consultant2016–2016
OK
Omid KarkoutiVice President of Business Development2017–2018
LL
Lawrence LeePrincipal Engineer / Head of Softwareformer
SB
Santhosh BalasubramanianDirector of Productformer

Investors · 37

AmasiareportedBurlingame · $100K – $5M

How we know: Y Combinator's founder network · Not right? Tell us

Amplify CapitalreportedToronto · $365K – $730K

How we know: Y Combinator's founder network · Not right? Tell us

Avlok CapitalreportedLynnwood

How we know: Y Combinator's founder network · Not right? Tell us

BEENEXTreportedSingapore

How we know: Y Combinator's founder network · Not right? Tell us

BEENOSreportedTokyo

How we know: Y Combinator's founder network · Not right? Tell us

BiovergereportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Founders FundreportedSan Francisco · $500K – $5M

How we know: funding news · Y Combinator's founder network · Not right? Tell us

Fuel CapitalreportedCovina · $500K – $1M

How we know: Y Combinator's founder network · Not right? Tell us

Fundamental VenturesreportedLakeway

How we know: Y Combinator's founder network · Not right? Tell us

H. BartonreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Horowitz Family OfficereportedNewport Beach

How we know: Y Combinator's founder network · Not right? Tell us

Lemonade Capitalreported

How we know: Y Combinator's founder network · Not right? Tell us

Locus VenturesreportedPalo Alto

How we know: the VCSheet dataset · Not right? Tell us

PreAngel FundreportedBeijing · $20K – $1M

How we know: Y Combinator's founder network · Not right? Tell us

Strontium Groupreported

How we know: Y Combinator's founder network · Not right? Tell us

Susa VenturesreportedSan Francisco · $1M – $5M

How we know: Y Combinator's founder network · Not right? Tell us

Upside PartnershipreportedMill Valley · $500K

How we know: Y Combinator's founder network · Not right? Tell us

WorldQuant VenturesreportedOld Greenwich

How we know: Y Combinator's founder network · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$82.2M disclosed across 6 rounds · 2014–2023

▶$10.3MraisedMar 2023 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph WagnerExecutive Officer
  • Matthew De SilvaDirector
  • Adam SeabrookDirector
  • James KimDirector
  • Thomas BockExecutive Officer, Director
Offering amount
$10.3M
Amount sold
$10.3M
Sales commissions
$310.1K
Placement agents
JMP Securities LLC
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.1MraisedJul 2022 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James KimDirector
  • Adam SeabrookDirector
  • Matthew De SilvaDirector
  • Thomas BockExecutive Officer, Director
Offering amount
$10.5M
Amount sold
$10.1M
First sale
Jun 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$39.8MraisedDec 2019 · 37 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew De SilvaExecutive Officer, Director
  • Michael HorowitzExecutive Officer
  • James KimDirector
  • Peter QuinzioExecutive Officer, Director
Offering amount
$44M
Amount sold
$39.8M
First sale
Jun 2019
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.8MraisedAug 2017 · 95 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • James KimDirector
  • Matthew De SilvaExecutive Officer, Director, Promoter
  • Pete QuinzioExecutive Officer, Director, Promoter
  • Amanda HermannExecutive Officer
Offering amount
$17.7M
Amount sold
$14.8M
First sale
Aug 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$2.7MraisedMar 2017 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter QuinzioExecutive Officer
  • Matthew De SilvaExecutive Officer, Director
Offering amount
$2.7M
Amount sold
$2.7M
Proceeds to insiders
$300K
First sale
May 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedMay 2016 · 40 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew De SilvaExecutive Officer, Director
  • Peter QuinzioExecutive Officer
Offering amount
$4.5M
Amount sold
$4.5M
Proceeds to insiders
$300K
First sale
Jul 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

The YC application· Winter 2015 batch

Related companies · 5

Companies working in the same space as Notable Labs.

Legal entities · 2

corporate structure
Notable Labs, Ltd.
Stemcycle Inc.

Frequently asked questions

What does Notable Labs do?
Notable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.
Who founded Notable Labs?
Notable Labs was founded by Matthew De Silva, Pete Quinzio in 2014.
Who are Notable Labs's investors?
Notable Labs's investors include 11.2 Capital, Alumni Ventures, Builders VC, FundersClub, Gaingels, Hemisphere Ventures LLC, Lifeforce Capital, Mission and Market and 29 more.
How much funding has Notable Labs raised?
Notable Labs has disclosed $82.2M raised across 6 rounds.
Where is Notable Labs headquartered?
Notable Labs is headquartered in San Francisco, US.